Answer
Co-administration of sotorasib with rosuvastatin increased rosuvastatin peak concentration (Cmax) by 70% and overall exposure (AUC) by 34%.
Sources for this answer
- LUMYKRAS 240 mg film-coated tabletsAmgen Ltd · emc · SmPC §4.5 Interaction with other medicinal products · Version 3Document updated
Sources checked